LSP-GR-1

N/A

Report date: 2024/12/26 16:31:47
NME

Base Information

Drug NameLSP-GR-1
Drug Alias NameLSP-GR-1
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionRNA splicing modulators
TargetsNot applicable
Therapy Area/IndicationsAmyotrophic Lateral SclerosisEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLifeSplice Pharma LLC
China Registration ClassN/A

Develop Information

Active CompaniesLifeSplice Pharma LLC
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral SclerosisEpilepsy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A